Unknown NA INTERVENTIONAL 2-arm
NCT05348161
Dynamic Multiomics Evaluation of Anti-HER2 and Immunotherapy in HER2 Positive Gastric Cancer
Sponsor: Peking University
Conditions
HER2 Positive Advanced Gastric Cancer
Interventions
10×genomics single cell RNA sequence CTC detection Proteomics detection Samples including blood and tissue collection Whole exon sequence ctDNA detection
Updated 4 times since 2022 Last updated: Apr 20, 2022 Started: Jan 1, 2019 Primary completion: Jan 1, 2023 Completion: Jan 1, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A NA clinical study on HER2 Positive Advanced Gastric Cancer, this trial is ongoing. The trial is conducted by Peking University and has accumulated 4 data snapshots since 2019. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
4 versions recorded-
Feb 2025 — Present [monthly]
Unknown NA
Status: Recruiting → Unknown
-
Sep 2024 — Feb 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
May 2022 — Jul 2024 [monthly]
Recruiting NA
First recorded
Jan 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Peking University
Data source: Peking University
For direct contact, visit the study record on ClinicalTrials.gov .